$111.58
arrow_drop_up1.86%Key Stats | |
---|---|
Open | $110.00 |
Prev. Close | $109.54 |
EPS | 4.83 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
LOW | HIGH | |
---|---|---|
Day Range | 109.32 | 110.57 |
52 Week Range | 99.06 | 146.70 |
Ratios | |
---|---|
EPS | 4.83 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
VEON’s Jazz Secures Pakistan’s Largest Long-Term Private Sector Syndicated Credit Facility of up to PKR 75 billion - GlobeNewswire
Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024 - GlobeNewswire
UBS cuts Jazz Pharmaceuticals target to $113 from $117 By Investing.com - Investing.com
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.